tiprankstipranks
CervoMed (CRVO)
NASDAQ:CRVO
US Market
CRVO
CervoMed
RESEARCH TOOLSreports
Want to see CRVO full AI Analyst Report?

CervoMed (CRVO) Stock News & Sentiment

1,257 Followers
Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed
Premium
Ratings
Neflamapimod’s MRI and Connectivity Data Support Disease‑Modifying Potential in Dementia With Lewy Bodies and Underscore Buy Rating on CervoMed
12d ago
CRVO
CervoMed Highlights Positive Phase 2b Neflamapimod MRI Results
Premium
Company Announcements
CervoMed Highlights Positive Phase 2b Neflamapimod MRI Results
12d ago
8K
CRVO
CervoMed Highlights Neflamapimod Progress in Lewy Body Dementia
Premium
Company Announcements
CervoMed Highlights Neflamapimod Progress in Lewy Body Dementia
27d ago
8K
CRVO
CervoMed Posts Investor Presentation Under Regulation FD Disclosure
Premium
Company Announcements
CervoMed Posts Investor Presentation Under Regulation FD Disclosure
1M ago
8K
CRVO
CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results
Premium
Company Announcements
CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results
2M ago
8K
CRVO
CervoMed Reports 2025 Results, Advances Neflamapimod Programs
Premium
Company Announcements
CervoMed Reports 2025 Results, Advances Neflamapimod Programs
2M ago
8K
CRVO
CervoMed: Compelling Neflamapimod Opportunity and Undervalued Shares Despite Near-Term Funding Overhang
Premium
Ratings
CervoMed: Compelling Neflamapimod Opportunity and Undervalued Shares Despite Near-Term Funding Overhang
2M ago
CRVO
More CRVO News >

CRVO News on the Web

Roth MKM Remains a Buy on CervoMed (CRVO)
TipRanks News
Bullish
CervoMed Highlights Neflamapimod Progress in Lewy Body Dementia
TipRanks News
Neutral
CervoMed (CRVO) Gets a Buy from JonesTrading
TipRanks News
Neutral
CervoMed Posts Investor Presentation Under Regulation FD Disclosure
TipRanks News
Neutral
CervoMed Highlights RewinD-LB Phase 2b Biomarker-Driven Results
TipRanks News
Neutral
CervoMed’s neflamapimod shows efficacy in dementia with DLB
TipRanks News
Bullish
CervoMed Narrows Cash Runway As It Prepares For Multiple 2026 Clinical Milestones
rttnews
Bullish
CervoMed price target lowered to $11 from $19 at Roth Capital
TipRanks News
Bullish

News Score - Last 7 Days

Neutral
CRVO
Sector Average
Media Buzz
This Week1 articles
Weekly Average3.25 articles
News Sentiment
This Week100%
Sector Average70%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is CRVO’s Media Buzz Sentiment?
1 articles about CRVO were published this week. In an average week, 3.25 articles are published.
    What is CRVO’s weekly average amount of articles?
    In an average week, 3.25 articles about CRVO are published.
      What is CRVO’s News Sentiment?
      100% of articles about CRVO were positive this week, compared to its sector average of 70%.
        Healthcare Stocks that are Trending in the News
        TVTXTravere Therapeutics
        HVOOpen Orphan Plc
        PBMPsyence Biomedical
        QDELQuidelOrtho
        Showing the stocks with the most bullish news sentiment over the past week